Prevalence of VKORC1 polymorphism in population of Hyderabad India
Authors:
- Livy AlexLALivy Alex
- Amrita RaoARAmrita Rao
- Gita SharmaGSGita Sharma
- R TapadiaRTR Tapadia
Open Access
- 1 January 2015
- journal article
- Published by Marwah Infotech in Acta Medica International
- Vol. 2 (2) , 108
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- VKORC1 Gene Analysis of Some Iranian Sensitive Patients to WarfarinPakistan Journal of Biological Sciences, 2010
- Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–AmericansPharmacogenomics, 2008
- Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarctionThrombosis Journal, 2008
- Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian populationClinical Pharmacology & Therapeutics, 2006
- A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivityHuman Molecular Genetics, 2005
- A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarinBlood, 2005
- VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulationThrombosis and Haemostasis, 2005
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction*1The Lancet, 1994
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993